血行力学的モニタリング装置の世界市場予測（～2021）...市場調査レポートについてご紹介

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Research Design
2.5 Market Data Validation and Triangulation
2.6 Assumptions for the Study

3 Executive Summary (Page No. – 29)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 34)
4.1 Overview of the Market, (2016-2021)
4.2 Market, By Product
4.3 Market, By Type
4.4 Market, By End User
4.5 Geographic Analysis of the Market

5 Market Overview (Page No. – 37)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Technological Advancements in Hemodynamic Monitoring Systems
5.3.1.1.1 Noninvasive Hemodynamic Monitoring Systems
5.3.1.1.2 Micro-Electro-Mechanical Systems (Mems) Technology
5.3.1.2 Increasing Initiatives By Industry Players
5.3.1.3 Rising Prevalence of Cardiovascular Diseases and Diabetes
5.3.1.4 Rapid Growth in Aging Population
5.3.2 Challenge
5.3.2.1 Risks Associated With Invasive Hemodynamic Monitoring
5.3.3 Opportunity
5.3.3.1 India and China Provide Significant Market Growth Opportunities

6 Hemodynamic Monitoring Systems Market, By Product (Page No. – 45)
6.1 Introduction
6.2 Systems (Monitors)
6.3 Disposables

7 Hemodynamic Monitoring Systems Market, By Type (Page No. – 52)
7.1 Introduction
7.2 Invasive Hemodynamic Monitoring Systems
7.3 Minimally Invasive Hemodynamic Monitoring Systems
7.4 Noninvasive Hemodynamic Monitoring Systems

8 Hemodynamic Monitoring Systems Market, By End User (Page No. – 63)
8.1 Introduction
8.2 Hospitals
8.3 Cath Labs
8.4 Home and Ambulatory Care

9 Global Hemodynamic Monitoring Systems Market, By Region (Page No. – 71)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.1.1 Technological Advancements in Hemodynamic Monitoring Systems in the U.S.
9.2.1.2 Initiatives Adopted By Industry Players to Boost Market in U.S.
9.2.1.3 Favorable Reimbursement Environment Likely to Drive the Hemodynamic Monitors Market
9.2.1.4 Increasing Prevalence of Hypertension
9.2.1.5 Growing Diabetes Prevalence to Boost the Market for Hemodynamic Monitoring Systems
9.2.2 Canada
9.2.2.1 Rising Usage of Heart Monitoring Systems in Canada
9.2.2.2 High Diabetes Prevalence to Boost the Market for Hemodynamic Monitoring Systems
9.3 Europe
9.3.1 Europe-5
9.3.1.1 Rising Prevalence of Diabetes and Cardiovascular Diseases in the U. K.
9.3.1.2 Initiatives Adopted By Nhs England for the Implementation of Hemodynamic Monitoring Systems
9.3.1.3 Conferences on Hemodynamic Monitoring Systems in European Countries
9.3.1.4 Active Involvement of Industry Players to Augment the Demand for Hemodynamic Monitoring System in Europe-5
9.3.1.5 S3 Guidelines for Intensive Care in Cardiac Surgeries
9.3.1.6 Odm as A Standard of Care in France
9.3.2 RoE
9.3.2.1 Hemodynamic Monitoring Systems Gaining Momentum in the Netherlands and Sweden
9.3.2.2 High Diabetes Prevalence in European Countries
9.4 Asia-Pacific
9.4.1 Japan
9.4.1.1 Active Involvement of LiDCO Group PLC in Japan
9.4.2 China
9.4.2.1 Company Initiatives to Enhance Product Availability in China
9.4.2.2 Rising Incidence of Diabetes and Rapidly Aging Population
9.4.3 India
9.4.3.1 High Diabetes Prevalence to Accelerate the Market Growth in India
9.4.4 RoAPAC
9.4.4.1 Adoption of Hemodynamic Monitoring Systems in Vietnam, Singapore, & Malaysia
9.4.4.2 Tensys Medical’s Marketing Strategy to Bolster the Market for Noninvasive Hemodynamic Monitoring in China and Taiwan
9.4.4.3 High Diabetes Prevalence and Rising Incidence of CVD in Pacific Countries
9.5 RoW
9.5.1 High Diabetes Prevalence in Brazil
9.5.2 LiDCO’s Marketing Strategy to Bolster the Market for Hemodynamic Monitoring in Africa
9.5.3 High Diabetes Prevalence Driving the Adoption of Hemodynamic Monitoring in the Middle East & Africa

10 Competitive Landscape (Page No. – 103)
10.1 Overview
10.2 Competitive Situation and Trends
10.3 Market Share Analysis
10.3.1 Introduction
10.3.2 Edwards Lifesciences Corporation
10.3.3 Pulsion Medical Systems Se
10.3.4 LiDCO Group PLC.
10.4 Competitive Scenario
10.4.1 Agreements, Collaborations, and Joint Ventures
10.4.2 Product Launches
10.4.3 Mergers and Acquisitions
10.4.4 Other Strategies

11 Company Profiles (Page No. – 113)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Edwards Lifesciences Corporation
11.2 Pulsion Medical Systems Se (Part of the Maquet Getinge Group)
11.3 LiDCO Group PLC
11.4 Cheetah Medical, Inc.
11.5 Deltex Medical Group PLC
11.6 Hemo Sapiens, Inc.
11.7 ICU Medical, Inc.
11.8 Osypka Medical GmbH
11.9 Schwarzer Cardiotek GmbH
11.10 Tensys Medical, Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 129)
12.1 Discussion Guide
12.2 Company Developments (2013–2016)
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports